132 related articles for article (PubMed ID: 19852981)
1. Successful treatment of immune reconstitution inflammatory syndrome in Whipple's disease using thalidomide.
Lagier JC; Fenollar F; Lepidi H; Liozon E; Raoult D
J Infect; 2010 Jan; 60(1):79-82. PubMed ID: 19852981
[TBL] [Abstract][Full Text] [Related]
2. Erythema nodosum-like lesions in treated Whipple's disease: signs of immune reconstitution inflammatory syndrome.
Schaller J; Carlson JA
J Am Acad Dermatol; 2009 Feb; 60(2):277-88. PubMed ID: 19150271
[TBL] [Abstract][Full Text] [Related]
3. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple's disease.
Lagier JC; Fenollar F; Lepidi H; Raoult D
J Antimicrob Chemother; 2010 Sep; 65(9):2005-12. PubMed ID: 20639526
[TBL] [Abstract][Full Text] [Related]
4. Previous immunosuppressive therapy is a risk factor for immune reconstitution inflammatory syndrome in Whipple's disease.
Biagi F; Trotta L; Di Stefano M; Balduzzi D; Marchese A; Vattiato C; Bianchi PI; Fenollar F; Corazza GR
Dig Liver Dis; 2012 Oct; 44(10):880-2. PubMed ID: 22704397
[TBL] [Abstract][Full Text] [Related]
5. [A case of Whipple's disease with ankylosing spondylarthritis treated with trimethoprim-sulfamethoxazole].
Blaison D; Carteret E; Renard P; Le Louargant M; Diebold MD; Lecocq P; Brochot P; Gougeon J; Zeitoun P
Ann Gastroenterol Hepatol (Paris); 1991; 27(2):51-5. PubMed ID: 1713437
[TBL] [Abstract][Full Text] [Related]
6. The immune reconstitution inflammatory syndrome in whipple disease: a cohort study.
Feurle GE; Moos V; Schinnerling K; Geelhaar A; Allers K; Biagi F; Bläker H; Moter A; Loddenkemper C; Jansen A; Schneider T
Ann Intern Med; 2010 Dec; 153(11):710-7. PubMed ID: 21135294
[TBL] [Abstract][Full Text] [Related]
7. Whipple's disease, successful response to sulfamethoxazole-trimethoprim.
Viteri AL; Greene JF; Chandler JB
Am J Gastroenterol; 1981 Apr; 75(4):309-10. PubMed ID: 6167162
[TBL] [Abstract][Full Text] [Related]
8. A patient with cerebral Whipple's disease and a stroke-like syndrome.
Famularo G; Minisola G; De Simone C
Scand J Gastroenterol; 2005 May; 40(5):607-9. PubMed ID: 16036516
[TBL] [Abstract][Full Text] [Related]
9. [Weight loss, joint pain and abdominal lymphadenopathy as signs of sarcoidosis, but also of Whipple's disease].
Deeren D; Vanderschueren S; Ectors N; Blockmans D; Bobbaers H
Ned Tijdschr Geneeskd; 2003 Mar; 147(13):620-4. PubMed ID: 12701398
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive therapy in Whipple's disease patients is associated with the appearance of gastrointestinal manifestations.
Mahnel R; Kalt A; Ring S; Stallmach A; Strober W; Marth T
Am J Gastroenterol; 2005 May; 100(5):1167-73. PubMed ID: 15842595
[TBL] [Abstract][Full Text] [Related]
11. A severe Whipple disease with an immune reconstitution inflammatory syndrome: an additional case of thalidomide efficiency.
Le Blay P; Rakotonirainy H; Lagier JC; Raoult D; Puechal X; Pers YM
Joint Bone Spine; 2014 May; 81(3):260-2. PubMed ID: 24289960
[TBL] [Abstract][Full Text] [Related]
12. Erythema Nodosum Leprosum-Like Lesions Are a Histopathologic Pattern in Whipple's Disease and a Sign of the Immune Reconstitution Inflammatory Syndrome: A Case Series and Review of the Literature.
Liersch J; Carlotti A; Theunis A; Leonard A; Barrett M; Carlson JA; Schaller J
Am J Dermatopathol; 2017 Apr; 39(4):259-266. PubMed ID: 28098596
[TBL] [Abstract][Full Text] [Related]
13. Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease.
Feurle GE; Moos V; Bläker H; Loddenkemper C; Moter A; Stroux A; Marth T; Schneider T
J Infect; 2013 Mar; 66(3):263-70. PubMed ID: 23291038
[TBL] [Abstract][Full Text] [Related]
14. [Whipple's disease in a man with weight loss and diarrhea].
Smit EG; Ferwerda J; Dekker W
Ned Tijdschr Geneeskd; 1999 Feb; 143(8):413-7. PubMed ID: 10221112
[TBL] [Abstract][Full Text] [Related]
15. Immunopathology of immune reconstitution inflammatory syndrome in Whipple's disease.
Moos V; Feurle GE; Schinnerling K; Geelhaar A; Friebel J; Allers K; Moter A; Kikhney J; Loddenkemper C; Kühl AA; Erben U; Fenollar F; Raoult D; Schneider T
J Immunol; 2013 Mar; 190(5):2354-61. PubMed ID: 23365082
[TBL] [Abstract][Full Text] [Related]
16. Therapy for Whipple's disease.
Knaapen HK; Barrera P
J Antimicrob Chemother; 2007 Sep; 60(3):457-8. PubMed ID: 17623695
[TBL] [Abstract][Full Text] [Related]
17. Whipple's disease: acquired resistance to trimethoprim-sulfamethoxazole.
Lévy M; Poyart C; Lamarque D; Delchier JC
Am J Gastroenterol; 2000 Sep; 95(9):2390-1. PubMed ID: 11007254
[No Abstract] [Full Text] [Related]
18. Cutaneous manifestations in treated Whipple's disease.
van der Bent S; van Vugt M; Amir A; van der Wal A; Mekkes J
Int J Dermatol; 2017 Apr; 56(4):e82-e84. PubMed ID: 28181229
[No Abstract] [Full Text] [Related]
19. [Whipple's disease. A case report and review of the literature].
Arce Salinas CA; Delgado Toledano MA; Larraza Hernández O; Mondragón Galicia R; Chavarrín Uruchurtu E; Olaeta Elizalde RF
Rev Gastroenterol Mex; 1990; 55(4):231-4. PubMed ID: 1708913
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS.
Brunel AS; Reynes J; Tuaillon E; Rubbo PA; Lortholary O; Montes B; Le Moing V; Makinson A
AIDS; 2012 Oct; 26(16):2110-2. PubMed ID: 22874513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
